GEN-001 is being developed for daily administration as an oral enteric capsule containing lyophilized bacteria. Early clinical development is due to begin in 2020 with a phase 1/2 study in the US ...

GEN-001 is being developed for daily administration as an oral enteric capsule containing lyophilized bacteria. Early clinical development is due to begin in 2020 with a phase 1/2 study in the US ...